ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2022 and some content may be unavailable. To unlock all content for 2022, please visit the archives.

Abstract: FR-PO598

Inflammatory Dendritic Cell Drive Intra-Renal T Cells to Double-Negative T Cell in Lupus Nephritis

Session Information

Category: Glomerular Diseases

  • 1302 Glomerular Diseases: Immunology and Inflammation

Authors

  • Ganesan, Latha Prabha, The Ohio State University Wexner Medical Center, Columbus, Ohio, United States
  • Bruckner, Shane, The Ohio State University Wexner Medical Center, Columbus, Ohio, United States
  • Saljoughian, Noushin, The Ohio State University Wexner Medical Center, Columbus, Ohio, United States
  • Turman, James M., The Ohio State University Wexner Medical Center, Columbus, Ohio, United States
  • Rajaram, Murugesan, The Ohio State University Wexner Medical Center, Columbus, Ohio, United States
  • Rovin, Brad H., The Ohio State University Wexner Medical Center, Columbus, Ohio, United States
  • Jarjour, Wael, The Ohio State University Wexner Medical Center, Columbus, Ohio, United States
  • Parikh, Samir V., The Ohio State University Wexner Medical Center, Columbus, Ohio, United States
Background

The pathogenesis of lupus nephritis (LN) is incompletely understood stalling progress and resulting in suboptimal patient outcomes. We previously identified a novel inflammatory dendritic cells (InfDC) accumulating in the peri-glomerular space adjacent to CD3+ T cells forming an immunologic synapse in human kidney biopsies at LN flare. Here, we aim to describe the T cell phenotype(s) in cross-talk with these infDC during LN flare. Characterizing these T cells will further our understanding of the major immune cells driving local inflammatory damage during LN.

Methods

Multi-color flow cytometry analysis was performed using antibodies against various immune cell markers, comparing proteinuria NZM 2410 mice and human-chimeric lupus mouse (Hu-lupus) mice with pre-proteinuric NZM (pre-prot-NZM) and humanized healthy (Hu-healthy) mice, respectively.

Results

FACS analysis of T cell phenotypes identified upregulation of double negative (CD4-CD8-) (DN) T cells, but not Th1 or Th17, in prot-NZM compared to pre-proteinuric. Also, the DN T cell frequencies paralleled infDC in the intra-renal space and the expression of both cell types correlated with proteinuria. There was no correlation between infDC and DN T cell kidney expression and proteinuria in lymph nodes or spleen. To relate our findings with human LN, we studied Hu-lupus mice and found significantly higher infDC and DN T cell expression compared to Hu-healthy mice. Importantly, the majority of CD3+ cells in the Hu-lupus mice were TCRαb+TCRgd-CD4-CD8-PD1+, suggesting a subtype of DN T that are known to be self-reactive and proinflammatory.

Conclusion

In this study, we demonstrate an increase in a novel subtype of pro-inflammatory DN T adjacent to infDC in NZM model of LN and in a humanized mouse model of LN. These infDC, DN T cell subtype and their relationship have not been previously described. These findings enhance our understanding of the mechanisms that drive intra-renal inflammation during LN. Targeting infDC or their associated DN T cell phenotype may attenuate renal inflammation and improve outcomes in LN.

Funding

  • NIDDK Support